Live news related to ABIVAX stock (FR0012333284): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The biotech company specializing in inflammatory diseases extends its decline this Monday, against the trend of an SBF 120 that remains stable during …
The biotech company specializing in inflammatory diseases is accelerating its decline this Thursday, in a Paris market itself under pressure. The stoc…
Following the presentation of its half-year results on September 21, the Paris-based biotech company continues its decline this Tuesday, in a market t…
Abivax presented its first-half 2026 accounts on September 21, 2026, marked by an increase in research and development expenses and a widened net loss…
The Parisian biotech company signs a rebound at the end of the session, while the market as a whole advances and the publication of its half-yearly re…
The Paris-based biotech closes the session in sharp decline, going against the grain of the SBF 120 which closes up. The stock is well below its three…
The Paris-based biotech is losing ground this Tuesday in a declining market, while short seller positions on the stock have increased by one percentag…
The Parisian biotech company closes down this Monday, following the publication of its first-half 2026 results. The stock loses ground as the SBF 120 …
The Parisian biotech continues its downward summer trend, losing ground in a Paris market itself slightly in the red. The decline widens the gap from …
The Parisian biotech company is losing ground this Friday, in a context of a well-oriented market, with the CAC 40 up more than 1% during the session.…
